Dr R Di Cuffa – Thyme GP
Why standard cholesterol tests don’t always tell the full story?
As a doctor, one of the most common things I hear from patients is:
“My cholesterol has always been normal, so why should I worry about my heart?”
It’s a fair question. For many years, cardiovascular risk assessment has relied heavily on standard cholesterol tests. While these remain useful, we now know they don’t capture the full picture of heart disease risk, particularly in people with a family history or early cardiovascular events.
Modern testing allows us to look more precisely at what actually drives artery disease, often years before symptoms develop.
Why heart disease can occur despite “normal” cholesterol?
Heart disease is not caused by cholesterol alone. It develops through a combination of:
- Cholesterol-carrying particles entering the artery wall
- Chronic low-grade inflammation
- Metabolic factors such as insulin resistance
- Genetic influences/blood pressure
Standard NHS lipid profiles measure cholesterol content, but not the number of particles, nor inherited or inflammatory risk.
That’s where advanced cardiovascular markers can be useful
Key tests we use and why they matter
Apolipoprotein B (ApoB)
ApoB reflects the number of atherogenic particles capable of causing plaque.
Two people with the same LDL cholesterol can have very different ApoB levels and very different cardiovascular risk.
From a clinical perspective, ApoB is one of the strongest predictors of heart disease available.
Lipoprotein(a) – Lp(a)
Lp(a) is an inherited cholesterol particle that significantly increases the risk of heart attack and stroke.
Important points for patients:
- It is largely genetic
- It is not influenced by diet or exercise
- It is not routinely measured on the NHS
- It helps explain family history of early heart disease
Knowing your Lp(a) allows us to tailor prevention more appropriately.
High-Sensitivity C-Reactive Protein (hs-CRP)
This measures low-grade inflammation, which plays a central role in plaque development and instability.
Even with well-controlled cholesterol, ongoing inflammation can increase your cardiovascular risk.
HbA1c (Average Blood Sugar)
Raised blood sugar damages blood vessels long before diabetes is diagnosed.
HbA1c allows us to:
- Identify early insulin resistance
- Assess long-term vascular risk
- Guide and support lifestyle and dietary intervention
Omega-3 Index / AA:EPA Ratio
These markers assess the balance of fatty acids involved in inflammation, clotting, and vascular health.
Low omega-3 levels are associated with:
- Increased inflammation
- Higher cardiovascular risk
- Poorer outcomes following cardiac events
Other advanced cardiac testing
For patients with a strong family history, unexplained risk, or who wish to take a proactive approach to prevention, we may recommend additional markers.
Lp-PLA2 (PLAC test)
This enzyme reflects inflammation within arterial plaque, helping identify plaque activity rather than plaque presence alone.
Fasting Insulin
Insulin resistance often precedes raised blood sugar by many years and is closely linked to cardiovascular disease.
Homocysteine
An independent vascular risk factor associated with endothelial damage (damage to the inner lining of blood vessels) and clotting tendency, sometimes influenced by genetics.
The role of genetics in heart disease
Some individuals do everything “right” yet still develop cardiovascular disease.
Genetic testing can identify inherited risk related to:
- Lipoprotein(a)
- Cholesterol handling
- Lipid metabolism
This information does not predict destiny, but it allows earlier and more targeted prevention.
How this fits with UK medical practice
These tests do not replace NHS care or QRISK scoring. Instead, they:
- Add precision to risk assessment
- Help explain discrepancies between cholesterol and family history
- Support personalised prevention strategies
They are particularly useful for:
- Patients with premature heart disease in the family
- Those with normal cholesterol but ongoing concern
- Individuals seeking proactive, preventative care
The aim: clarity and prevention
As doctors, our goal is not to over-test or alarm patients. It is to:
- Identify genuine risk early
- Focus on modifiable factors
- Personalise advice and treatment
- Reduce long-term cardiovascular events
Heart disease develops silently over decades. The earlier we understand the drivers, the more effectively we can intervene.
If you are concerned about your cardiovascular risk or family history, discussing advanced testing may help provide reassurance or identify where prevention should be more focused. Get in touch to discuss the next steps with our team.
